Algernon Pharmaceuticals Hits Co-Primary Endpoint in its Phase 2 Study of Ifenprodil for Idiopathic Pulmonary Fibrosis and Chronic Cough | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.
Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF – Get Rating) was the target of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 3,900 shares, a decrease of 64.9% from the June 15th total of 11,100 shares. Based on an average daily volume of 4,000 shares, the […]
Co-Diagnostics Inc (NASDAQ:CODX) announced it has shipped testing reagents for the monkeypox virus, currently exhibiting a multi-country outbreak, to one of.
Algernon Pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF), a clinical stage Canadian pharmaceutical development company, has provided an update on its chronic.
Co-Diagnostics Inc (NASDAQ:CODX) announced it has shipped testing reagents for the monkeypox virus, currently exhibiting a multi-country outbreak, to one of.